SEDECIB
7 866,98 R$
Preço máximo ao consumidor (CMED)
Analogs of SEDECIB
Find cheaper analogs and generic equivalents for SEDECIB.
Princípio ativo: palbociclib
Visão geral do produto
About SEDECIB
SEDECIB is a medication containing the active ingredient palbociclib, classified as Kinase Inhibitor. Palbociclib, sold under the brand name Ibrance among others, is an anti-cancer medication used for the treatment of HR-positive and HER2-negative breast cancer. It was developed by Pfizer. It is a selective inhibitor of the cyclin-dependent kinases CDK4 and CDK6.
Key Benefits & Uses
- Used for: 1 INDICATIONS AND USAGE IBRANCE is a kinase inhibitor indicated: • for the treatment of adult patients with hormone receptor (HR)-positive, human.
- Use only as directed on the product label or by a healthcare professional.
- Follow the authorised product information for dosing and duration of use.
Active Ingredient & Action
palbociclib, the active ingredient in SEDECIB, belongs to the Kinase Inhibitor class. 1 INDICATIONS AND USAGE IBRANCE is a kinase inhibitor indicated: • for the treatment of adult patients with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced or metastatic breast cancer in combination with: o an aromatase inhibitor as initial endocrine-based therapy ( 1. Inactive ingredients: not listed in source data.
Important Notes
Always read and follow the label instructions carefully before taking SEDECIB. If you have any underlying medical conditions, are taking other medicines, or are pregnant or breastfeeding, consult a doctor or pharmacist before use. Do not exceed the recommended dose on the package and do not use SEDECIB for extended periods without medical advice.
Visitor ratings
Help others by rating how useful this product page is.
No ratings yet — be the first.